Researchers say psilocybin, the active compound in the mushrooms, should be reclassified to treat anxiety and depression. But any such move would be years away.
Read More...
Get The New York Times on your mobile device
Read More...
Get The New York Times on your mobile device
Sent from my iPhone
No comments:
Post a Comment